• IN MEMORIAM: Roland R. Griffiths, Ph.D
  Published on 2023-12-10
  2 years ago
• Factors influencing JUUL e-cigarette nicotine vapour-induced reward, withdrawal, pharmacokinetics and brain connectivity in rats: sex matters
  Published on 2023-12-06
  2 years ago
• Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer’s disease
  Published on 2023-12-05
  2 years ago
• Activation of prefrontal parvalbumin interneurons ameliorates working memory deficit even under clinically comparable antipsychotic treatment in a mouse model of schizophrenia
  Published on 2023-12-03
  2 years ago
• Greater subjective effects of a low dose of LSD in participants with depressed mood
  Published on 2023-12-01
  2 years ago
• ACNP 62nd Annual Meeting: Poster Abstracts P501 – P753
  Published on 2023-11-30
  2 years ago
• ACNP 62nd Annual Meeting: Panels, Mini-Panels and Study Groups
  Published on 2023-11-30
  2 years ago

« Previous 1 … 55 56 57 58 59 … 143 Next »

• Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study
  Published on 2022-05-02
  3 years ago
• Differences in social brain function in autism spectrum disorder are linked to the serotonin transporter: A randomised placebo-controlled single-dose crossover trial
  Published on 2022-05-01
  3 years ago
• Regulation of clock and clock-controlled genes during morphine reward and reinforcement: Involvement of the period 2 circadian clock
  Published on 2022-04-29
  3 years ago
• The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review
  Published on 2022-04-29
  3 years ago
• Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment
  Published on 2022-04-27
  3 years ago
• A letter to the editor, associated with the article entitled “Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium” by Vázquez et al. (Journal of Psychopharmacology, 2021, Vol. 35(8) 890–900)
  Published on 2022-04-27
  3 years ago
• Hyodeoxycholic acid inhibits lipopolysaccharide-induced microglia inflammatory responses through regulating TGR5/AKT/NF-κB signaling pathway
  Published on 2022-04-27
  3 years ago

« Previous 1 … 55 56 57 58 59 … 124 Next »

• Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder
  Published on 2022-10-07
  3 years ago
• Stress, mental disorder and ketamine as a novel, rapid acting treatment
  Published on 2022-10-05
  3 years ago
• Corrigendum to ‘No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial’ [European Neuropsychopharmacology 53 (2021) 34–46]
  Published on 2022-10-02
  3 years ago
• A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs
  Published on 2022-10-01
  3 years ago
• Pros and cons of esketamine treatment in psychiatry
  Published on 2022-09-30
  3 years ago
• The role of metformin as a treatment for neuropsychiatric illness
  Published on 2022-09-30
  3 years ago
• Minor physical anomalies in bipolar disorder in comparison to healthy controls and schizophrenia: A systematic review and meta-analysis
  Published on 2022-09-21
  3 years ago

« Previous 1 … 55 56 57 58 59 … 145 Next »